179 related articles for article (PubMed ID: 28067351)
1. Targeted combinational therapy inducing mitochondrial dysfunction.
Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS
Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351
[TBL] [Abstract][Full Text] [Related]
2. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
3. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
Pathak RK; Wen R; Kolishetti N; Dhar S
Mol Cancer Ther; 2017 Apr; 16(4):625-636. PubMed ID: 28148716
[TBL] [Abstract][Full Text] [Related]
4. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment.
Kumar R; Han J; Lim HJ; Ren WX; Lim JY; Kim JH; Kim JS
J Am Chem Soc; 2014 Dec; 136(51):17836-43. PubMed ID: 25402959
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
Idowu T; Samadder P; Arthur G; Schweizer F
Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
Hu Q; Gao M; Feng G; Liu B
Angew Chem Int Ed Engl; 2014 Dec; 53(51):14225-9. PubMed ID: 25318447
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Prodrug Capable of Mitochondria-Targeting, Light-Triggered Release, and Fluorescence Monitoring.
Jung YL; Yang YJ; Shil A; Sarkar S; Ahn KH
ACS Appl Bio Mater; 2024 Jun; 7(6):3991-3996. PubMed ID: 38835291
[TBL] [Abstract][Full Text] [Related]
9. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
Montagner D; Tolan D; Andriollo E; Gandin V; Marzano C
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486477
[TBL] [Abstract][Full Text] [Related]
10. A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells.
Yuan Y; Zhang CJ; Liu B
Chem Commun (Camb); 2015 May; 51(41):8626-9. PubMed ID: 25898264
[TBL] [Abstract][Full Text] [Related]
11. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
12. Dual approach: micellar delivery of chlorambucil prodrug with concurrent glutathione depletion and GST inhibition for enhanced anticancer activity.
Wu S; Liao K; Chen J; Li F
Nanotechnology; 2024 Jun; 35(34):. PubMed ID: 38788695
[TBL] [Abstract][Full Text] [Related]
13. Aromatic oligopeptides with chlorambucil moiety--synthesis and biological evaluation.
Bartulewicz D
Acta Pol Pharm; 2005; 62(6):451-5. PubMed ID: 16583984
[TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity.
Xie R; Li Y; Tang P; Yuan Q
Bioorg Med Chem Lett; 2017 Sep; 27(18):4415-4420. PubMed ID: 28818449
[TBL] [Abstract][Full Text] [Related]
15. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
Millard M; Gallagher JD; Olenyuk BZ; Neamati N
J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
[TBL] [Abstract][Full Text] [Related]
16. Alternative mechanism of action of the DNP Pt
Krasnovskaya O; Spector D; Erofeev A; Gorelkin P; Akasov R; Skvortsov D; Trigub A; Vlasova K; Semkina A; Zyk N; Beloglazkina E; Majouga A
Dalton Trans; 2021 Jun; 50(23):7922-7927. PubMed ID: 34037020
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological studies of the thiols-triggered anticancer prodrug for a more effective cancer therapy.
Xu Y; Chen J; Li Y; Peng S; Gu X; Sun M; Gao K; Fang J
Org Biomol Chem; 2015 Mar; 13(9):2634-9. PubMed ID: 25581090
[TBL] [Abstract][Full Text] [Related]
18. Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance.
Ma J; Li L; Yue K; Li Y; Liu H; Wang PG; Wang C; Wang J; Luo W; Xie S
Bioorg Chem; 2020 Jun; 99():103768. PubMed ID: 32217375
[TBL] [Abstract][Full Text] [Related]
19. Developing glutathione-activated catechol-type diphenylpolyenes as small molecule-based and mitochondria-targeted prooxidative anticancer theranostic prodrugs.
Bao XZ; Dai F; Wang Q; Jin XL; Zhou B
Free Radic Biol Med; 2019 Apr; 134():406-418. PubMed ID: 30707929
[TBL] [Abstract][Full Text] [Related]
20. Prodrug strategy for cancer cell-specific targeting: A recent overview.
Zhang X; Li X; You Q; Zhang X
Eur J Med Chem; 2017 Oct; 139():542-563. PubMed ID: 28837920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
